Compare HBIO & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBIO | PRT |
|---|---|---|
| Founded | 1901 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil & Gas Production |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 21.5M |
| IPO Year | 2000 | N/A |
| Metric | HBIO | PRT |
|---|---|---|
| Price | $8.26 | $1.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 34.6K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 13.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | N/A |
| Revenue This Year | $3.76 | $654.36 |
| Revenue Next Year | $5.29 | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $1.53 |
| 52 Week High | $8.80 | $4.01 |
| Indicator | HBIO | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 17.63 |
| Support Level | $5.91 | N/A |
| Resistance Level | $8.30 | $2.32 |
| Average True Range (ATR) | 0.35 | 0.08 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 40.56 | 1.46 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.